All News

Patients with hemophilia A across all age groups reported stabilization or improvement of quality of life and high treatment satisfaction.

The trial analyzed the impact of vitamin K intake on patients who were taking warfarin to decrease the risk of blood clots.

Top news of the day from across the health care landscape.

In the statement, USPSTF officials noted that people who take PrEP should continue to use condoms and practice other behaviors to reduce their risk of other sexually transmitted infections.

Pembrolizumab is now indicated for use as a first-line monotherapy treatment for metastatic or unresectable recurrent head and neck squamous cell carcinoma.

An unhealthy microbiome caused by chronic antibiotic treatment could result in long-term inflammation within the tissue and tumor environment.

Top news of the day from across the health care landscape.

The Neostigmine Methylsulfate Injection is the first manufacturer-prepared, ready-to-administer prefilled syringe on the market.

Polatuzumab vedotin-piiq (Polivy) is a first-of-its-kind anti-CD76b antibody-drug conjugate used in combination with bendamustine plus rituximab (Rituxan) for previously-treated diffuse large B-cell lymphoma.

Zolgensma is the first gene therapy indicated for the treatment of children with spinal muscular atrophy.

Expanded mental health care at HIV clinics across the United States could help in reaching the goal of viral suppression among 90% of the population.

Top news of the day from across the health care landscape.

Why is a patient being prescribed an unusually high dose of loratadine?

Dietary supplements have become a booming industry, but there are many safety concerns associated with these products since they are not required to be reviewed by the FDA before they are marketed.

E-cigarettes have been under much scrutiny since use among youth has increased.

Balancing guidelines with providing individualized patient care can be a challenge for pharmacists.